Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|November 22, 2019
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year studyA Sulli, S Paolino, C Pizzorni, et al.
Lupus|March 25, 2015
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin DS Piantoni, L Andreoli, M Scarsi, et al.
Reumatismo|November 7, 2013
Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary resultsE Bernero, A Sulli, G Ferrari, et al.
Reumatismo|December 21, 2012
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patientsS Soldano, P Montagna, R Brizzolara, et al.
Clinical Rheumatology|July 15, 2018
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patientsC Pizzorni, M Cutolo, A Sulli, et al.
Annals of the Rheumatic Diseases|October 28, 2008
Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblastsS Soldano, P Montagna, B Villaggio, et al.
Clinical and Experimental Rheumatology|January 9, 2007
Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern EuropeM Cutolo, K Otsa, K Laas, et al.
British Journal of Rheumatology|September 1, 1996
Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide)G F Ferraccioli, O Della Casa-Alberighi, E Marubini, et al.
Microvascular Research|August 24, 2017
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patientsB Ruaro, A Sulli, C Pizzorni, et al.
Annals of the New York Academy of Sciences|July 13, 2002
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapyM Cutolo, A Sulli, C Pizzorni, et al.
Pageof 22